BIOPHYTIS S.A.
Sorbonne University—BC 9, Bâtiment A 4ème étage
4 place Jussieu
75005 Paris, France
+33 1 44 27 23 00
April 27, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549
Attention: Sean Healy
Re: Biophytis S.A. (the “Registrant”) - Request for Acceleration
Registration Statement on Form F-3
File No. 333- 271385
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the Registrant hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (File No. 333- 271385) (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on Monday, May 1, 2023, or as soon thereafter as practicable.
The Registrant hereby authorizes Wendy Grasso of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Wendy Grasso at (212) 549-0216.
BIOPHYTIS S.A. | ||
By: | /s/ Stanislas Veillet | |
Name: | Stanislas Veillet | |
Title: | Chief Executive Officer and Chairman |